5028 Delp Bldg, Mail stop 1011 — Kansas City, Kansas

5028 Delp Bldg, Mail stop 1011 is a clinical research site located in Kansas City, Kansas, United States 66160.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

5028 Delp Bldg, Mail stop 1011 has participated in 1 clinical trials.

Therapeutic areas: Deep Partial Thickness Burn, Full Thickness Burns.

Sponsors: Molnlycke Health Care AB.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 5028 Delp Bldg, Mail stop 1011?

5028 Delp Bldg, Mail stop 1011 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 5028 Delp Bldg, Mail stop 1011 conducted?

5028 Delp Bldg, Mail stop 1011 has 1 clinical trials on record. Their work covers Deep Partial Thickness Burn, Full Thickness Burns.

Is 5028 Delp Bldg, Mail stop 1011 accredited by Crixeo Health?

5028 Delp Bldg, Mail stop 1011 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 5028 Delp Bldg, Mail stop 1011?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.